HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Neil Gross Selected Research
Neil Gross Research Topics
Disease
13
Neoplasms (Cancer)
05/2021 - 11/2009
8
Squamous Cell Carcinoma of Head and Neck
01/2020 - 11/2009
4
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 01/2012
4
Melanoma (Melanoma, Malignant)
12/2018 - 11/2014
4
Anaplastic Thyroid Carcinoma
12/2018 - 01/2018
3
Head and Neck Neoplasms (Head and Neck Cancer)
01/2018 - 11/2012
3
Hemorrhage
01/2018 - 11/2013
2
Hypopharyngeal Neoplasms
01/2020 - 10/2018
2
Carcinogenesis
10/2018 - 01/2012
2
Laryngeal Neoplasms (Laryngeal Cancer)
01/2018 - 11/2017
1
Weight Loss (Weight Reduction)
02/2024
1
Malnutrition (Nutritional Deficiencies)
02/2024
1
Oropharyngeal Neoplasms
02/2024
1
Tertiary Lymphoid Structures
05/2021
1
Lymphoma (Lymphomas)
05/2021
1
B-Cell Lymphoma (Lymphoma, B Cell)
05/2021
1
Carcinoma (Carcinomatosis)
01/2020
1
Carcinosarcoma
01/2019
1
Exanthema (Rash)
11/2018
1
Long Term Adverse Effects
01/2018
1
Thromboembolism
01/2018
1
Neoplasm Metastasis (Metastasis)
11/2014
1
Lymphocele
12/2011
1
Fanconi Anemia (Fanconi's Anemia)
11/2009
1
Inflammation (Inflammations)
11/2009
1
Genomic Instability
11/2009
Drug/Important Bio-Agent (IBA)
9
Biomarkers (Surrogate Marker)
IBA
01/2020 - 01/2012
5
Immune Checkpoint Inhibitors
IBA
01/2023 - 11/2018
4
MicroRNAs (MicroRNA)
IBA
12/2019 - 01/2012
3
Proteins (Proteins, Gene)
FDA Link
01/2020 - 11/2009
2
DNA (Deoxyribonucleic Acid)
IBA
12/2019 - 12/2018
2
Messenger RNA (mRNA)
IBA
01/2018 - 11/2017
1
cemiplimab
IBA
05/2021
1
Monoclonal Antibodies
IBA
05/2021
1
olaparib
IBA
01/2020
1
Fluorouracil (Carac)
FDA Link
Generic
10/2019
1
2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))
IBA
10/2019
1
Cisplatin (Platino)
FDA Link
Generic
10/2019
1
Esters
IBA
10/2019
1
Paclitaxel (Taxol)
FDA Link
Generic
10/2019
1
B7-H1 Antigen
IBA
01/2019
1
Cell-Free Nucleic Acids
IBA
12/2018
1
Ipilimumab
IBA
11/2018
1
Apoptosis Regulatory Proteins
IBA
11/2018
1
Nivolumab
IBA
11/2018
1
pembrolizumab
IBA
11/2018
1
Phosphotransferases (Kinase)
IBA
11/2018
1
Ligands
IBA
11/2018
1
lenvatinib
IBA
01/2018
1
trametinib
IBA
01/2018
1
Interleukin-23 (Interleukin 23)
IBA
01/2018
1
Interleukin-12 Receptors (Interleukin 12 Receptor)
IBA
01/2018
1
dabrafenib
IBA
01/2018
1
Tyrosine Kinase Inhibitors
IBA
11/2012
1
Sulindac (Copal)
FDA Link
Generic
11/2012
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
11/2012
1
Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
IBA
11/2012
1
ErbB Receptors (EGF Receptor)
IBA
11/2012
1
Epidermal Growth Factor (EGF)
IBA
11/2012
1
Blood Proteins (Serum Proteins)
IBA
11/2012
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2012
1
Transforming Growth Factor beta1 (TGF beta 1)
IBA
11/2009
1
Smad4 Protein
IBA
11/2009
1
Transforming Growth Factor beta (TGF-beta)
IBA
11/2009
Therapy/Procedure
9
Therapeutics
05/2021 - 11/2013
5
Radiotherapy
01/2020 - 11/2014
3
Drug Therapy (Chemotherapy)
10/2019 - 01/2018
2
Enteral Nutrition (Feeding, Tube)
02/2024 - 01/2018
2
Neoadjuvant Therapy
05/2021 - 11/2012
2
Neck Dissection (Radical Neck Dissection)
01/2019 - 11/2014
1
Aftercare (After-Treatment)
02/2024
1
Immunotherapy
01/2023
1
Gas Lasers
01/2019
1
Laryngectomy
01/2019
1
Adjuvant Chemotherapy
01/2018
1
Perioperative Period
01/2018
1
Tracheostomy
01/2018
1
Robotic Surgical Procedures
01/2017
1
Ligation
01/2017
1
Lymph Node Excision (Lymph Node Dissection)
11/2014
1
Sclerotherapy
12/2011